Research utilizing the Eμ-TCL1 mouse model of CLL demonstrated that the upregulation of IDO in MDSCs leads to an elevated kynurenine to tryptophan ratio in the serum, correlating with enhanced immunosuppression and progression of leukemia 128. Here, IDO1 is linked to B-cell chronic lymphocytic leukemia.